110 related articles for article (PubMed ID: 15163284)
1. Rosiglitazone plus metformin: combination therapy for Type 2 diabetes.
Del Prato S; Volpe L
Expert Opin Pharmacother; 2004 Jun; 5(6):1411-22. PubMed ID: 15163284
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
Cox SL
Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
4. Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Pokharna H; Kanna B
Diabetes Obes Metab; 2007 Nov; 9(6):914. PubMed ID: 17394564
[No Abstract] [Full Text] [Related]
5. [Blood sugar inspite of maximal metformin dosage. New fixed combination forces HbA1c down].
MMW Fortschr Med; 2003 Dec; 145(50):54. PubMed ID: 14963975
[No Abstract] [Full Text] [Related]
6. Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
Bailey CJ; Day C
Int J Clin Pract; 2004 Sep; 58(9):867-76. PubMed ID: 15529521
[TBL] [Abstract][Full Text] [Related]
7. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.
Smiley D; Umpierrez G
Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome.
Sinha SK; Bhangoo A; Anhalt H; Maclaren N; Marshall JD; Collin GB; Naggert JK; Ten S
J Pediatr Endocrinol Metab; 2007 Sep; 20(9):1045-52. PubMed ID: 18038714
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
10. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
Stafford JM; Elasy T
Vasc Health Risk Manag; 2007; 3(4):503-10. PubMed ID: 17969380
[TBL] [Abstract][Full Text] [Related]
11. Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.
Derosa G; Tinelli C; Maffioli P
Diabetes Obes Metab; 2009 Dec; 11(12):1091-9. PubMed ID: 19765050
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study.
Li X; Zhang N; Li Y; Shi Y; Li D; Xie Y; Xie Y; Ming J
J Int Med Res; 2011; 39(2):358-65. PubMed ID: 21672339
[TBL] [Abstract][Full Text] [Related]
13. Response to Pokharna and Kanna: initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Garber A
Diabetes Obes Metab; 2008 May; 10(5):436-7. PubMed ID: 17596200
[No Abstract] [Full Text] [Related]
14. Rosiglitazone/Metformin.
Wellington K
Drugs; 2005; 65(11):1581-92; discussion 1593-4. PubMed ID: 16033298
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Scheen AJ
Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
17. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
19. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
20. A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
Seufert J
Curr Med Res Opin; 2006; 22 Suppl 2():S39-48. PubMed ID: 16914074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
